NSETrading Window23 Jun 2026 · 23 Jun 2026, 05:09 pm
Trading Window
Entero Healthcare Solutions Limited · ENTERO
✦ AI Summary
Entero Healthcare Solutions Limited has announced the closure of its trading window for Designated Persons and their immediate relatives, effective July 01, 2026. This is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. The date for the Board Meeting to consider these results will be intimated subsequently.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
ENTERO_23062026170844_Trading_Window_Closure.pdf
View document text
Ref: 15/SE/LC/2026-27 Date: June 23, 2026
Scrip Code BSE: 544122
NSE: ENTERO
ISIN: INE010601016
Head, Listing Compliance Department Head, Listing Compliance Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1. G Block,
Mumbai - 400001. Bandra -Kurla Complex, Bandra (East),
Mumbai- 400051
Dear Sir/Madam,
Subject: Intimation of Closure of Trading Window
This is to inform you that pursuant to the Company’s Code of Fair Disclosure of Unpublished
Price Sensitive Information framed pursuant to the Securities and Exchange Board of India
(Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading Window for
dealing in securities of the Company by the Designated Persons of the Company and their
immediate relatives will be closed with effect from July 01, 2026 and shall remain closed up
to 48 (Forty Eight) hours after declaration of the Unaudited Financial Results of the Company
for the quarter ended June 30, 2026.
The date of the Board Meeting to consider the aforesaid Unaudited Financial Results of the
Company will be intimated in due course of time.
This is for your information and records.
Yours Faithfully
For Entero Healthcare Solutions Limited
Sanu Kapoor
Vice President- General Counsel, Company Secretary
& Compliance Officer